News
Recent News
01/27/2026
Higher Medicine Announces Strategic Investment by Cerdwen to Accelerate Therapies for Kabuki Syndrome and Other Brain Disorders
Higher Medicine Inc. announced a strategic investment and fundraising partnership with Cerdwen, a venture capital firm focused on health and performance technology innovation. Based in West Chester, Pennsylvania, Cerdwen partners with visionary founders to advance transformative healthcare technologies, supporting the translation of bold scientific ideas into meaningful clinical and commercial impact. “Higher Medicine exemplifies the …
01/27/2026
Epidarex Capital Announces First Close of Fund IV, Securing $145 Million to Build the Next Wave of Life Science Startups
Epidarex Capital (“Epidarex”), a transatlantic life science venture firm, today announces the first close of Epidarex Capital IV, LP, securing more than $145 million in commitments to build therapeutics and medical device companies. The Fund’s initial investors include the British Business Bank, Strathclyde Pension Fund, the Scottish National Investment Bank, as well as leading family …
01/20/2026
Vibrent Health Joins a Landmark BARDA-Funded Large-Scale Hybrid/Remote Decentralized Clinical Research Study
Vibrent Health, a leading software-as-a-service (SaaS) data company in the field of precision medicine research, is collaborating with Fred Hutch Cancer Center (Fred Hutch) under a $17 million contract awarded through the Biomedical Advanced Research and Development Authority’s (BARDA) Rapid Response Partnership Vehicle (RRPV) Consortium. This collaboration drives critical research on correlates of protection (CoPs), …